Topical Imiquimod Treatment for Nodular Basal Cell Carcinomas: An Open-Label Series

Dermatologic Surgery

Volumn 30, Issue 3, 2004, Pages 429-430

  Huber, Amy ^a   Huber, John D ^b,c   Skinner Jr , Robert B ^a   Kuwahara, Raymond T ^d   Haque, Raashid ^d   Amonette, Rex A ^a,b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Memphis Dermatology Clinic Tennessee   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ARTICLE; BASAL CELL CARCINOMA; CHEMOSURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG EFFICACY; ERYTHEMA; FOLLOW UP; HUMAN; MICROSURGERY; OPEN STUDY; PAIN; PRIORITY JOURNAL; SKIN BIOPSY; SKIN NODULE; SKIN ULCER; TUMOR RECURRENCE;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; FOLLOW-UP STUDIES; HUMANS; PROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 1942504386     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30116.x     Document Type: Article

References (8)

1. Beutner KR, Geisse JK, Helman D, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999;41:1002-7.
2. Drehs MM, Cook B, Olden F, Tranzi EL, Weinberg JM. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature. Dermatol Surg 2002;28:427-9.
3. Chen TM, Rosen T, Orengo I. Treatment of a large superficial basal cell carcinoma with 5% imiquimod: a case report and review of the literature. Dermatol Surg 2002;28:344-6.
4. Cowen E, Mercurio MG, Gaspari AA. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. J Am Acad Dermatol 2002;47:S240-8.
5. Dahl MV. A cytokine inducer. J Am Acad Dermatol 2002;47: S205-8.
6. Dahl MV. Imiquimod: an immune response modifier. J Am Acad Dermatol 2000;43:S1-5.
7. Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001;44:807-13.
8. Shumack S, Robinson J, Kossard S, et al. Efficacy of topical imiquimod 5% cream for the treatment of nodular basal cell carcinoma: comparison of dosage regimens. Arch Dermatol 2002; 138:1165-71.